Drawing for C+ CPLUS BIOTECH

USPTO serial 79341950

C+ CPLUS BIOTECH

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KAPLAN, VALERIE ELIZABETH
Law office
TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with C+ CPLUS BIOTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Biochemical preparations other than for medical use; biological activators; biological preparations (other than for medical or veterinary purposes); biological preparations for laboratory purposes; biological preparations for use in biotechnology (other than medical); biological preparations for use in manufacture; biological products (other than for medical use); biological substances (other than for medical or veterinary use); biological tissue cultures for scientific or research purposes; biological tissue cultures, other than for medical or veterinary purposes; chemical products for biotechnological purposes (scientific); chemical products for use in biotechnology (other than for medical or veterinary use); culture media for microbiology; biological preparations for use in cell cultures (other than medical); cultures of cell media (other than for medical or veterinary use); cultures, other than for medical or veterinary use; media for cell culture for use in the biotechnological industry; stem cells for research or scientific purposes; stem cells other than for medical or veterinary purposes; none of the aforesaid goods relating to detection of autoantibodies reacting with peptides or the diagnosis of Rheumatoid ArthritisACTIVE—
005Biochemicals for pharmaceutical use; biological products for medical use; biological tissue cultures for medical purposes; chemical preparations for biotechnological purposes (medical); chemical preparations for use in biotechnology (medical or veterinary use); cultures for medical use; cultures for pharmaceutical use; cultures of cell media for medical use; biochemical preparations for medical use; biological preparations for medical purposes; biological preparations for use in biotechnology (medical); biological preparations for use in cell cultures (medical); medical preparations; microbiological cultures for medical purposes; biological preparations for pharmaceutical purposes; pharmaceutical preparations; stem cells for medical purposes; therapeutic biological products (medical); none of the aforesaid goods relating to detection of autoantibodies reacting with peptides or the diagnosis of Rheumatoid ArthritisACTIVE—
009Apparatus for laboratory use (other than medical); bioreactor apparatus; bioreactor instruments; bioreactors for research use; cell culture apparatus for laboratory use; cell culture instruments for laboratory use; instruments for scientific research in laboratories; insulated vessels for laboratory use; culture dishes; laboratory articles (other than for medical use); apparatus for scientific research in laboratories; research apparatus for scientific use; scientific apparatus; scientific apparatus for laboratory use (other than for medical diagnosis); none of the aforesaid goods relating to detection of autoantibodies reacting with peptides or the diagnosis of Rheumatoid ArthritisACTIVE—
010Cell culture apparatus for medical use; cell culture instruments for medical use; pharmaceutical apparatus; medical diagnostic apparatus for laboratory use; therapeutic apparatus (medical); none of the aforesaid goods relating to detection of autoantibodies reacting with peptides or the diagnosis of Rheumatoid ArthritisACTIVE—
035Online retail services; retail services; retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail services for goods [by any means]; wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesaling of goods (by any means); none of the aforesaid services relating to detection of autoantibodies reacting with peptides or the diagnosis of Rheumatoid ArthritisACTIVE—
042Advisory services relating to science; biochemistry services; biological research; biotechnology research; biotechnology testing; chemistry services; clinical trials; design of products; laboratory testing services; pharmaceutical research services; preparation of scientific reports; development of new products; product development; provision of scientific information; research and development of products; research relating to biotechnology; scientific and technological services; scientific consultancy; laboratory services (scientific research or analysis); providing information, including online, about scientific and technological services and research and design relating thereto; scientific research; scientific research in the field of pharmacy; scientific research into the development of new products; scientific research relating to biology; scientific research relating to cosmetics; scientific testing services; none of the aforesaid services relating to detection of autoantibodies reacting with peptides or the diagnosis of Rheumatoid ArthritisACTIVE—
044Advisory services relating to health; information services relating to health care; medical advisory services; advisory services relating to pharmaceutical products; pharmaceutical advisory services; provision of health care services; none of the aforesaid services relating to detection of autoantibodies reacting with peptides or the diagnosis of Rheumatoid ArthritisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 14, 2024FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 29, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 29, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 3, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 15, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 15, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 28, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 28, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 28, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 7, 2023ATRVATTORNEY REVIEW COMPLETED—
Apr 24, 2023LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW—
Mar 6, 2023RFNTREFUSAL PROCESSED BY IB—
Feb 13, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 13, 2023RFRRREFUSAL PROCESSED BY MPU—
Jan 30, 2023LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 17, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 16, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2022DOCKASSIGNED TO EXAMINER—
Sep 17, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 14, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 10, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 9, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance